Vanda Pharmaceuticals Inc (VNDA)
Net Income Growth
-129.77%
Quarterly · Period ending:
VNDA Net Income Growth
Year-over-year change vs the same period a year earlier
Latest reported-129.77%period ending
Latest reported-129.77%period ending
VNDA Quarterly Net Income YoY % (-208.87% → -129.77%)
Year-over-year change
High-resolution chart · PNG
VNDA net income growth history
Quarterly. Dates are reporting period ends; fiscal years can differ from calendar years.
| Period ending | Net Income Growth |
|---|---|
| -129.7681% | |
| -64.6674% | |
| -2,774.3282% | |
| -324.2299% | |
| -502.1912% | |
| -611.3845% | |
| -104.6667% | |
| -3,986.1314% | |
| -397.2368% | |
| -227.4908% | |
| -134.9803% | |
| -95.8104% | |
| -40.9479% | |
| 150.5754% | |
| -3.0658% | |
| -57.9205% | |
| -73.3347% | |
| -174.3353% | |
| -13.5775% | |
| 30.6709% | |
| 10.7758% | |
| 1,679.8354% | |
| 94.26% | |
| -94.078% | |
| -24.397% | |
| 179.4118% | |
| -59.305% | |
| 1,300.4044% | |
| 149.9675% | |
| -119.9609% | |
| 663.6561% | |
| 257.6044% | |
| 400.5867% | |
| 140.1046% | |
| -204.3046% | |
| -958.1395% | |
| 66.7822% | |
| 38.1372% | |
| 95.9184% | |
| 95.455% | |
| 14.2592% | |
| -20.9079% | |
| -121.2252% | |
| -563.4642% | |
| 75.0359% | |
| 61.4782% | |
| 1,014.5874% | |
| 73.4944% | |
| -600.7145% | |
| -535.8255% | |
| -19.6891% | |
| -1.0139% | |
| 61.5461% | |
| 47.5885% | |
| -15.3178% | |
| -73.2596% | |
| -497.0917% | |
| -5,954.4118% | |
| -351.1811% | |
| -196.5306% | |
| -204.8196% | |
| -74.3088% | |
| 123.8034% | |
| 141.2211% | |
| 110.3238% | |
| 108.1391% | |
| -23.0992% | |
| 28.9243% | |
| 8.1718% | |
| 66.1182% | |
| 63.8333% | |
| 50.4673% | |
| 15.578% | |
| -24.7088% | |
| -74.4813% | |
| -80.9899% | |
| 25.2096% | |
| 15.0625% | |
| -73.7535% | |
| -112.5223% | |
| -290.865% | |
| -208.8675% |